After finishing at $3.25 in the prior trading day, AN2 Therapeutics Inc (NASDAQ: ANTX) closed at $3.01, down -7.38%. In other words, the price has decreased by -$0.2400 from its previous closing price. On the day, 529899 shares were traded.
Ratios:
Our goal is to gain a better understanding of ANTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.87 and its Current Ratio is at 7.87. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On February 13, 2024, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform and also lowered its target price recommendation from $23 to $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 18 ’24 when Zakrzewski Joseph S sold 100,000 shares for $19.11 per share. The transaction valued at 1,911,410 led to the insider holds 405,880 shares of the business.
Aziz Kabeer sold 100,000 shares of ANTX for $1,965,000 on Jan 16 ’24. The Director now owns 377,542 shares after completing the transaction at $19.65 per share. On Jan 16 ’24, another insider, Adjuvant Global Health Technol, who serves as the 10% Owner of the company, sold 84,093 shares for $19.65 each. As a result, the insider received 1,652,427 and left with 1,995,958 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANTX now has a Market Capitalization of 89.61M and an Enterprise Value of -5.64M.
Stock Price History:
Over the past 52 weeks, ANTX has reached a high of $22.22, while it has fallen to a 52-week low of $2.72. The 50-Day Moving Average of the stock is 7.2606, while the 200-Day Moving Average is calculated to be 12.5536.
Shares Statistics:
The stock has traded on average 434.57K shares per day over the past 3-months and 381.89k shares per day over the last 10 days, according to various share statistics. A total of 29.74M shares are outstanding, with a floating share count of 17.90M. Insiders hold about 39.89% of the company’s shares, while institutions hold 54.87% stake in the company. Shares short for ANTX as of Mar 15, 2024 were 319.42k with a Short Ratio of 0.74, compared to 336.25k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.07% and a Short% of Float of 1.55%.
Earnings Estimates
Its stock is currently analyzed by 4 different market analysts. On average, analysts expect EPS of -$0.62 for the current quarter, with a high estimate of -$0.56 and a low estimate of -$0.67, while EPS last year was -$0.79. The consensus estimate for the next quarter is -$0.63, with high estimates of -$0.54 and low estimates of -$0.73.
Analysts are recommending an EPS of between -$2.19 and -$3.05 for the fiscal current year, implying an average EPS of -$2.61. EPS for the following year is -$2.77, with 5 analysts recommending between -$1.83 and -$4.03.
